
About Leukocare
Leukocare is a Healthcare company based in Munchen (Germany) founded in 2003. Proprietary stabilizing solutions for biologics formulations are developed. Leukocare has raised $17.5 million across 2 funding rounds from investors including Petrichor and LifeCare Partners. The company has 70 employees. Leukocare offers products and services including Formulation Development, Data Science Services, Stability Studies, and Particle Characterization. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its legal entity is LEUKOCARE AG.
Company details
Leukocare offers a proprietary formulation platform for the development of biologics. Their proprietary Stabilising and Protecting Solutions (SPS) platform offers technologies for increasing the stability and protection of therapeutic proteins in dry and liquid formulations. The platform mainly includes three major functionalities namely thermal stabilization, sterilization protection (for terminal sterilization and dry formulation of biologics) and device functionalization (for medical devices). The platform can be used mainly for the development of therapeutic antibodies, biosimilars, vaccines and medical devices. The company recently entered into a strategic alliance with Rentschler Biotechnologie, a Germany-based CDMO through which Leukocare would become its specialized technology partner and exclusive formulation developer.
- Headquarters Munchen, Germany
- Employees 70
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website leukocare.com
- Social LinkedIn X
- Legal Name Leukocare Ag
- Total Equity Funding$17.5M (USD)
in 2 rounds
- Latest Funding Round$17.5M (USD), Series B
Jun 2021
- InvestorsPetrichor
& 1 more
- Employee Count70
Products & Services of Leukocare
Leukocare offers a comprehensive portfolio of products and services, including Formulation Development, Data Science Services, Stability Studies, and Particle Characterization.
Optimizes formulations for biopharmaceuticals to enhance stability and efficacy.
Applies AI and bioinformatics for drug development and risk reduction.
Evaluates drug product stability under various conditions for safety.
Analyzes particles in drug substances to ensure quality and manufacturability.
Funding Insights of Leukocare
Leukocare has successfully raised a total of $17.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $17.5 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.5M
- Total Rounds 2
- Last Round Series B β $17.5M
- Investors Count 2
All 2 funding rounds of Leukocare with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $17.5M | Series B | β | Petrichor | β |
| Jul 2015 | Series A | β | β |
2 investors in total: 2 institutional.
Investors in Leukocare
Leukocare has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Petrichor and LifeCare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Petrichor is engaged in supporting healthcare innovation through investments. | 2018 | petrichorcap.com | New York, USA | |
LifeCare Partners is involved in unspecified activities. | lifecare.partners |
Investor details for Leukocare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Leukocare
23 people are tracked at Leukocare (10 in leadership, 11 in board & advisors, 2 in team); the tracked headcount is 70.
| Name | Role | Group |
|---|---|---|
Praveen Huber, Ph.D. | Vice President, Head Of Partnerships And Client Project Management | Leadership |
Georg Dönges | CFO | Leadership |
Dirk Winnemöller | VP, Head of Commercial | Leadership |
Michael Scholl | CEO | Leadership |
Konstadinos Salassidis | Director BD Marketing and Sales | Leadership |
Andreas Seidl | COO | Leadership |
Cornelius Pompe | VP, Head of R&D | Leadership |
Dr. Thea Böhm | Director Business Development | Leadership |
Marlen Polzer | Manager People & Organization / People Partner | Leadership |
Teresa Tänzer | Head Of People & Organization | Leadership |
Bernhardt L. Trout | Advisor | Board & advisors |
Jaul-Paul Prieels | Supervisory Board Member | Board & advisors |
Wolfgang Schwandner | Supervisory Board Member | Board & advisors |
Harald Mosler | Chair of the Supervisory Board | Board & advisors |
Paul Dalby | Advisor | Board & advisors |
Ulrike Protzer | Advisor | Board & advisors |
Gerhard Ries | Supervisory Board Member | Board & advisors |
Andreas Rummelt | Supervisory Board Member | Board & advisors |
Theodore W. Randolph | Advisor | Board & advisors |
Frank Mathias | Supervisory Board Member | Board & advisors |
3 more people are available in the full profile.
Complete people profiles for Leukocare
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Leukocare
3 dated milestones of Leukocare across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Leukocare is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $17.5M.
Web traffic of Leukocare
The website of Leukocare (leukocare.com) receives about 5.7K visits a month.
- Monthly visits5.7K
▲ 73.5% vs previous month
Websites whose visitors overlap most with Leukocare. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| viramed.de | 100% | View details | |||
| project-pharmaceutics.com | 99% | View details | |||
amicusrx.de | amicusrx.de | 99% | #10,724,948 | β | |
| eisbach.bio | 99% | 1.7K | #10,492,522 | View details | |
| mk2.bio | 98% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 22 similar websites and full traffic analytics for Leukocare
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Leukocare
Complete news archive for Leukocare
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leukocare
Leukocare was founded in 2003 and raised its 1st funding round 12 years after it was founded.
Leukocare is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Leukocare is a funded company, having raised a total of $17.5M across 2 funding rounds to date.
Leukocare has 70 employees.
Leukocare offers a proprietary formulation platform for the development of biologics. Their proprietary Stabilising and Protecting Solutions (SPS) platform offers technologies for increasing the stability and protection of therapeutic proteins in dry and liquid formulations. The platform mainly includes three major functionalities namely thermal stabilization, sterilization protection (for terminal sterilization and dry formulation of biologics) and device functionalization (for medical devices). The platform can be used mainly for the development of therapeutic antibodies, biosimilars, vaccines and medical devices. The company recently entered into a strategic alliance with Rentschler Biotechnologie, a Germany-based CDMO through which Leukocare would become its specialized technology partner and exclusive formulation developer.
Leukocare offers Formulation Development, Data Science Services, Stability Studies, and Particle Characterization.
Leukocare has 2 investors. Key investors include Petrichor, and LifeCare Partners.
Leukocare operates through Leukocare Ag.
